BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19409042)

  • 21. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter.
    Park SY; Kwak W; Thapa N; Jung MY; Nam JO; So IS; Kim SY; Yoo J; Lee J; Kim IS
    J Nucl Med; 2008 Sep; 49(9):1480-8. PubMed ID: 18703598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas.
    Cho JY; Shen DH; Yang W; Williams B; Buckwalter TL; La Perle KM; Hinkle G; Pozderac R; Kloos R; Nagaraja HN; Barth RF; Jhiang SM
    Gene Ther; 2002 Sep; 9(17):1139-45. PubMed ID: 12170377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
    Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
    Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional activity of human sodium/iodide symporter in tumor cell lines.
    Petrich T; Knapp WH; Pötter E
    Nuklearmedizin; 2003 Feb; 42(1):15-8. PubMed ID: 12601449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A transporter gene (sodium iodide symporter) for dual purposes in gene therapy: imaging and therapy.
    Cho JY
    Curr Gene Ther; 2002 Dec; 2(4):393-402. PubMed ID: 12477251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells.
    Schipper ML; Weber A; Béhé M; Göke R; Joba W; Schmidt H; Bert T; Simon B; Arnold R; Heufelder AE; Behr TM
    Cancer Res; 2003 Mar; 63(6):1333-8. PubMed ID: 12649195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of experimental NIS-expressing breast cancer brain metastases in response to radioiodide/gemcitabine dual therapy.
    Renier C; Do J; Reyna-Neyra A; Foster D; De A; Vogel H; Jeffrey SS; Tse V; Carrasco N; Wapnir I
    Oncotarget; 2016 Aug; 7(34):54811-54824. PubMed ID: 27363025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomerase-driven expression of the sodium iodide symporter (NIS) for in vivo radioiodide treatment of cancer: a new broad-spectrum NIS-mediated antitumor approach.
    Riesco-Eizaguirre G; De la Vieja A; Rodríguez I; Miranda S; Martín-Duque P; Vassaux G; Santisteban P
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1435-43. PubMed ID: 21697253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioiodide imaging and treatment of ARO cancer xenograft in a mouse model after expression of human sodium iodide symporter.
    Hsieh YJ; Ke CC; Liu RS; Wang FH; Tang KT; Chi CW; Chen FD; Lee CH
    Anticancer Res; 2007; 27(4B):2515-22. PubMed ID: 17695547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of myocardial sodium/iodide symporter gene expression imaging with radioiodide: evaluation with a dual-gene adenovirus vector.
    Lee KH; Kim HK; Paik JY; Matsui T; Choe YS; Choi Y; Kim BT
    J Nucl Med; 2005 Apr; 46(4):652-7. PubMed ID: 15809488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo radioiodide imaging and treatment of pancreatic cancer xenografts after MUC1 promoter-driven expression of the human sodium-iodide symporter.
    Chen RF; Li ZH; Pan QH; Zhou JJ; Tang QB; Yu FY; Zhou QB; Wang J; Chen JS
    Pancreatology; 2007; 7(5-6):505-13. PubMed ID: 17912014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
    Spitzweg C; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
    Cancer Res; 2000 Nov; 60(22):6526-30. PubMed ID: 11103823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy.
    Nakamoto Y; Saga T; Misaki T; Kobayashi H; Sato N; Ishimori T; Kosugi S; Sakahara H; Konishi J
    J Nucl Med; 2000 Nov; 41(11):1898-904. PubMed ID: 11079502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium iodide symporter/radioactive iodine system has more efficient antitumor effect in three-dimensional spheroids.
    Mitrofanova E; Hagan C; Qi J; Seregina T; Link C
    Anticancer Res; 2003; 23(3B):2397-404. PubMed ID: 12894520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between apoptosis imaging and radioiodine therapy in tumor cells with different sodium iodide symporter gene expression.
    Jung KO; Youn H; Kim YH; Kim S; Na J; Kim YI; Park JW; Kang KW; Lee DS; Chung JK
    Mol Imaging; 2014; 13():. PubMed ID: 25431214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.
    Spitzweg C; Baker CH; Bergert ER; O'Connor MK; Morris JC
    Hum Gene Ther; 2007 Oct; 18(10):916-24. PubMed ID: 17931047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.
    Müller AM; Schmohl KA; Knoop K; Schug C; Urnauer S; Hagenhoff A; Clevert DA; Ingrisch M; Niess H; Carlsen J; Zach C; Wagner E; Bartenstein P; Nelson PJ; Spitzweg C
    Oncotarget; 2016 Aug; 7(34):54795-54810. PubMed ID: 27458162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation.
    Kelkar MG; Senthilkumar K; Jadhav S; Gupta S; Ahn BC; De A
    Sci Rep; 2016 Jan; 6():19341. PubMed ID: 26777440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
    Kogai T; Taki K; Brent GA
    Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic retinoic acid treatment induces sodium/iodide symporter expression and radioiodide uptake in mouse breast cancer models.
    Kogai T; Kanamoto Y; Che LH; Taki K; Moatamed F; Schultz JJ; Brent GA
    Cancer Res; 2004 Jan; 64(1):415-22. PubMed ID: 14729653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.